Celcuity Investor Relations Material
Latest events
Q1 2025
Celcuity
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Celcuity Inc
Access all reports
Celcuity Inc. is a biotechnology company focused on developing diagnostic tests to improve the treatment of cancer. The company specializes in functional cellular analysis, using its proprietary CELsignia platform to identify molecular and cellular changes in a patient’s cancer cells. This technology helps detect new cancer subtypes and matches patients with targeted therapies that are most likely to be effective. The company is headquartered in Minneapolis, Minnesota, and its shares are listed on the NASDAQ.
Key slides for Celcuity Inc
Corporate Presentation
Celcuity Inc
Corporate Presentation
Celcuity Inc
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
CELC
Country
🇺🇸 United States